drugset / Trial / NCT07661979

Opzelura Experience Study

NCT07661979

Phase 4 Not yet recruiting 50 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsened by the complexity of recommended treatment algorithms. Giving patients a simple, one drug approach may be advantageous.

Timeline

Start
2026-08
Primary completion
2027-08
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ruxolitinib Small molecule Topical

Indications